Aller au contenu
Skip to content
Single Peptide Dosages

GHK-Cu (50mg Vial) Dosage Protocol

Copper tripeptide for skin remodeling/repair — research/educational dosing reference.

Single Peptide Dosages Updated November 26, 2025 11 min read Research information only
GHK-Cu (50mg Vial) Dosage Protocol
Quick answerIn the research literature, the 50 mg GHK-Cu vial is generally reconstituted with 3 mL of bacteriostatic water, and documented research protocols reference roughly 1 mg per dose drawn from that reconstituted solution. These figures describe reported research handling and are provided solely for research-use-only, non-clinical purposes.

Reconstitution calculator

Mix & measure GHK-Cu · 50 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Concentrationmg/mL
Draw volumemL
On the syringeunits
Doses / vial 

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

GHK-Cu Injection Dosage Chart & Reconstitution Guide

A single practical dilution with accurate dosing, step by step

Standard / Conservative Approach (3 mL = ~16.67 mg/mL; 5 days/week)

Reconstitute: Add 3.0 mL bacteriostatic water to one 50 mg vial → final concentration ~16.67 mg/mL (16,670 mcg/mL).

Typical range: 1.0–2.0 mg per injection, raised gradually over an 8–12 week course; start low to gauge tolerance.

Easy measuring: At ~16.67 mg/mL, 1 unit ≈ 0.167 mg on a U-100 syringe. For doses of 10 units or less, a 30- or 50-unit insulin syringe improves readability.

Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.

Phase / Week(s) Dose Volume (U-100 units / mL)
Weeks 1–4 1.0 mg (1000 mcg) 6 units (0.06 mL)
Weeks 5–8 1.5 mg (1500 mcg) 9 units (0.09 mL)
Weeks 9–12+ 2.0 mg (2000 mcg) 12 units (0.12 mL)

Ask what generic AI won't
ChatGPT dodges your GHK-Cu dosing questions. OpenPeptide answers them.
Documented protocols, exact reconstitution math, and real sources — no lectures, no dead ends.

Why researchers study it

Why GHK-Cu draws research interest

These are the directions researchers and the peptide community most often explore GHK-Cu for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Skin & collagen remodeling

The primary reason people look up GHK-Cu: a copper tripeptide studied in cosmetic and preclinical research on collagen synthesis and skin remodeling.

Wound & tissue repair

Investigated in animal and cell-culture research on wound healing and connective-tissue repair; not an approved medical treatment.

Hair growth research

Explored in preclinical and cosmetic studies on follicle activity and hair growth as a copper-peptide of interest.

Antioxidant & anti-inflammatory activity

Researched in cell and animal models for antioxidant and anti-inflammatory activity; findings remain investigational.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

01 · At a glance

Quickstart Highlights

GHK-Cu is a naturally-occurring copper tripeptide — glycyl-L-histidyl-L-lysine bound to copper(II) — that the body produces and that declines with age[1][2]. It is reported to take part in tissue remodeling, collagen and elastin synthesis, wound repair and antioxidant defense. This educational page outlines a once-daily subcutaneous approach with a dilution chosen so doses land on easy-to-read insulin-syringe marks. Almost all of GHK-Cu’s evidence is topical, in-vitro or animal; there are no completed controlled human trials of injectable GHK-Cu, and injectable GHK-Cu is an unapproved research chemical — presented for research and educational use only.

Reconstitute

Add 3.0 mL bacteriostatic water to one 50 mg vial → ~16.67 mg/mL, a concentration that keeps small doses on readable U-100 marks.

Daily range

1.0–2.0 mg per injection, started low and titrated upward; most reference patterns use 5 days/week or 3×/week.

Easy measuring

At ~16.67 mg/mL, 1 unit ≈ 0.167 mg; 1 mg ≈ 6 units and 2 mg ≈ 12 units on a U-100 syringe.

Storage

Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.

Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

02 · Dosing & reconstitution

Frequency: one subcutaneous injection 5 days per week, titrating up as tolerated[5][6]. This gradual titration lets you assess individual tolerance while keeping injection volumes practical. These figures come from reference patterns, not from approved human dosing.

Reconstitution Steps

1

Draw 3.0 mL of bacteriostatic water into a sterile syringe.

2

Release it slowly down the vial’s inner wall to limit foaming.

3

Swirl or roll gently until the deep-blue solution is fully dissolved — don’t shake.

4

Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.

Alternative Approach (3 mL = ~16.67 mg/mL; 3× weekly)

Phase / Week(s) Dose Volume (U-100 units / mL)
Weeks 1–12+ 2.0 mg (2000 mcg) 12 units (0.12 mL)

Frequency: Inject 2 mg three times per week (e.g., Monday / Wednesday / Friday)[6]. This maintains a steady weekly total of about 6 mg with fewer injections.

Note

Reconstituted GHK-Cu is an intense blue from the copper-peptide complex; this is expected. Avoid freezing the mixed solution, since freeze–thaw can degrade the peptide.

03 · What you’ll need

Supplies Needed

Quantities below assume an 8–16 week course; figures are shown for both 5 days/week and 3×/week patterns.

Peptide Vials (GHK-Cu, 50 mg each)

A 50 mg vial covers several weeks of dosing, so most courses need only 1–3 vials.

  • 5 days/week (~1–2 mg/day): ~1–3 vials
  • 3×/week (2 mg): ~1–2 vials
  • 16 weeks: ~3 vials
Insulin Syringes (U-100, 1 mL)
  • Per injection: 1 syringe
  • 8 weeks (5 days/week): ~40 syringes
  • 16 weeks (5 days/week): ~80 syringes
Bacteriostatic Water (10 mL bottles)

Use ~3.0 mL per 50 mg vial for reconstitution.

  • 1–2 vials: ~3–6 mL1 bottle
  • 3 vials: ~9 mL1 bottle
Alcohol Swabs

One for the vial stopper + one for the injection site each time.

  • Per injection: 2 swabs
  • 8 weeks (5 days/week): ~80 swabs1 box
GHK-Cu (50 mg Vial)
Peptide Vial

View Supplier

Insulin Syringes
Insulin Syringes

View Supplier

Bacteriostatic Water
Bacteriostatic Water

View Supplier

Alcohol Pads
Alcohol Pads

View Supplier

Protocol Overview

A concise summary of the regimen, drawn from commonly cited reference patterns for GHK-Cu.

  • Goal: Support skin remodeling, collagen/elastin synthesis and tissue repair via the copper tripeptide — effects reported mainly from topical, in-vitro and animal work, not established in humans by injection[3][5].
  • Schedule: Subcutaneous injections 5 days per week (or 3×/week) for 8–12 weeks, optionally extended to ~16 weeks.
  • Dose Range: 1.0–2.0 mg per injection with gradual titration.
  • Reconstitution: 3.0 mL bacteriostatic water per 50 mg GHK-Cu vial gives ~16.67 mg/mL for accurate unit measurements.
  • Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested titration approach based on common reference doses for GHK-Cu.

  • Start: Begin at 1.0 mg per injection to gauge tolerability.
  • Titrate: Increase by roughly 0.5 mg every four weeks as tolerated.
  • Target: Reach about 1.5–2.0 mg per injection by weeks 5–12.
  • Cycle Length: Typically 8–12 weeks; some references extend to ~16 weeks.
  • Timing: Inject at a consistent time and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the copper peptide’s stability and activity.

  • Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 30 days; do not freeze the mixed solution, as freezing can degrade peptides[8].
  • Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the deep-blue solution clear of heat and direct light.
  • Freeze–thaw: Avoid repeated freeze–thaw cycles of the reconstituted solution.
04 · Good to know

Important Notes

Practical points that keep administration safe and consistent.

  • Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
  • Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
  • Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow.
  • Recordkeeping: Log the dose, injection site and any observations to keep the protocol consistent.
  • Regulatory note: Injectable GHK-Cu is not FDA-approved for human administration and is sold only as a research chemical[10].
05 · How it works

How This Works

GHK-Cu is a naturally-occurring copper tripeptide — the sequence glycyl-L-histidyl-L-lysine (GHK) bound to a copper(II) ion. It occurs in human plasma, saliva and urine, and its levels decline with age[1][2]. GHK has a high affinity for copper and acts as a carrier that helps shuttle copper into cells.

In laboratory and animal studies, GHK-Cu is reported to stimulate collagen and elastin synthesis, support wound healing and angiogenesis, act as an antioxidant and anti-inflammatory, and modulate the expression of genes tied to skin repair and tissue remodeling[3][4][5]. These are the mechanisms most often cited for its cosmetic use.

It is important to be clear about where the evidence comes from: GHK-Cu is used overwhelmingly topically in cosmetics, where most of its human data — small studies of creams and serums for skin firmness, fine lines and wound repair — actually lies[6]. The collagen, anti-aging and healing claims rest largely on topical, in-vitro and animal data.

Important caveat: there are no completed controlled human clinical trials of injectable or systemic GHK-Cu. The systemic (subcutaneous) use described here is unproven and unapproved — benefits seen with topical or in-vitro GHK-Cu should not be assumed to transfer to injection, and the safety of injected copper-peptide is not established.

Injectable GHK-Cu is not an approved medicine. It is an unapproved research chemical presented here for research and educational purposes only.

06 · Daily habits

Lifestyle Factors

Habits that may support skin and tissue health alongside the protocol.

  • Nutrition: Keep protein and micronutrient intake adequate to give collagen and tissue repair the building blocks they need.
  • Sun protection: Daily SPF and UV avoidance limit the photo-damage that GHK-Cu is most often used to address.
  • Sleep: Aim for 7–9 hours to support the body’s natural repair processes.
  • Stress: Manage stress with evidence-based practices, since it influences skin and overall healing.
07 · What to expect

Potential Benefits & Side Effects

What topical, in-vitro and animal literature describe; human evidence is largely topical and injectable use is unproven.

Reported Benefits

  • Skin remodeling (topical/in-vitro): GHK-Cu is reported to boost collagen and elastin and improve skin firmness in topical and cell studies[3][6].
  • Wound healing & antioxidant (preclinical): Animal and lab work links GHK-Cu to faster wound repair, angiogenesis and antioxidant activity[4][5].
  • Gene modulation (in-vitro): GHK-Cu has been reported to shift the expression of many genes toward tissue repair in cultured cells[5].
  • Note on injection: These benefits are not established for injected GHK-Cu in humans — no controlled clinical trials of systemic GHK-Cu have been completed[11].

Possible Side Effects

  • Injection-site reactions: Mild redness, tenderness or transient blue discolouration at the site can occur; rotating sites helps.
  • Copper exposure: Because the molecule delivers copper, the long-term effect of repeated systemic copper-peptide dosing is unknown; caution and monitoring are advised.
  • Unknown human safety: Injectable GHK-Cu has no completed human safety data, so treat it as experimental.
08 · Injection technique

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[12][13].

Pre-Injection Preparation

  • Wash your hands well with soap and water.
  • Wipe the vial stopper with an alcohol swab and let it air-dry.
  • Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully[13].
  • Draw the intended dose, then check for air bubbles and push any out.

Injection Procedure

  • Pinch a skinfold at the chosen site between thumb and forefinger.
  • Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[12].
  • Skip aspiration for subcutaneous shots — it isn’t needed[12].
  • Press the plunger slowly and steadily until it’s fully down.
  • Wait 5–10 seconds, then pull the needle straight out to prevent leakage.

Post-Injection Care

  • Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
  • Return the reconstituted vial to the fridge right away.
  • Rotate the injection site each time to prevent irritation and lipohypertrophy[9].
  • Watch the site for excess redness, swelling, or signs of infection.
10 · The evidence

References

  1. 1
    Cosmetics / MDPI (PubMed)
    GHK and GHK-Cu: the human copper tripeptide, its decline with age and roles in tissue remodeling.

    View Source

  2. 2
    BioMed Research International (PubMed)
    GHK-Cu chemistry: glycyl-L-histidyl-L-lysine copper complex and copper transport.

    View Source

  3. 3
    International Journal of Molecular Sciences (PubMed)
    GHK-Cu stimulation of collagen, elastin and dermal matrix synthesis in skin models.

    View Source

  4. 4
    Journal of Aging Research (PubMed)
    GHK-Cu antioxidant, anti-inflammatory and wound-healing activity in preclinical models.

    View Source

  5. 5
    Gene expression analysis (PubMed)
    GHK-mediated modulation of gene expression toward tissue repair in cultured human cells.

    View Source

  6. 6
    Clinical / topical cosmetic studies (PubMed)
    Topical copper-peptide trials for skin firmness, fine lines and photoaging — the bulk of human GHK-Cu evidence.

    View Source

  7. 7
    Peptide Storage Guide
    Best practices for storing lyophilized peptides (temperature, humidity and light protection).

    View Source

  8. 8
    Bacteriostatic Water Guidance
    Bacteriostatic water for injection: multi-dose vial stability and handling.

    View Source

  9. 9
    NCBI Bookshelf
    Best practices for subcutaneous injection: aseptic technique and site rotation.

    View Source

  10. 10
    U.S. Food & Drug Administration
    GHK-Cu is not an FDA-approved drug for injection; injectable copper-peptide is sold as a research chemical.

    View Source

  11. 11
    ClinicalTrials.gov
    Trial registry search for GHK / copper-peptide; no completed efficacy trials of injectable systemic GHK-Cu.

    View Source

  12. 12
    Centers for Disease Control and Prevention (CDC)
    Subcutaneous injection technique: angle, site and no-aspiration guidance.

    View Source

  13. 13
    Subcutaneous Injection Technique (Patient Education)
    How to administer a subcutaneous injection: clinical technique guidelines.

    View Source

  14. 14
    Prime Lab Peptides
    GHK-Cu (50 mg) product page — purity specifications and certificates of analysis.

    View Source

Read the complete guide Peptide Dosage Chart Where to source it Which suppliers we lab-tested — purity, price and shipping compared
FAQ

GHK-Cu — frequently asked questions

How do I reconstitute a 50 mg vial of GHK-Cu?

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.

How much bacteriostatic water should I add to GHK-Cu?

There is no single correct amount — more water simply spreads the same 50 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.

What do the "units" on an insulin syringe mean?

On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.

How should I store GHK-Cu after mixing?

Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.

How many doses does a 50 mg vial of GHK-Cu provide?

Divide the vial strength of 50 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.

Is GHK-Cu approved for human use?

No. GHK-Cu is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Stay precise

New protocols & dosing updates

Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.